NDC 47426-303-03 - ZYNRELEF
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 47426-303
- Requested NDC
- 47426-303-03
- Package NDCs from labels
- 47426-303-05, 47426-303-03, 47426-303-01
- Manufacturer
- Heron Therapeutics, Inc. | Lifecore Biomedical | Apitoria Pharma, Ltd. | Cambrex Karlskoga AB | Pharma Packaging Solutions
- Effective date
- 2026-04-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ZYNRELEF | Heron Therapeutics, Inc. | Lifecore Biomedical | Apitoria Pharma, Ltd. | Cambrex Karlskoga AB | Pharma Packaging Solutions | 2026-04-20 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 47426-303-01 | ZYNRELEF | 1 in 1 KIT | SOLUTION | 1 | 16 | |
| 47426-303-03 | ZYNRELEF | 1 in 1 CARTON | SOLUTION | 1 | 16 | |
| 47426-303-05 | ZYNRELEF | 7 mL in 1 VIAL, SINGLE-DOSE | SOLUTION | 7 | 16 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 47426-303-01 | ML - Milliliter | 47426-303 | 0b064ca7-9930-47f3-9cc5-4e827e3002b1 | 1 | 2021-07-15 |
| 47426-303-05 | ML - Milliliter | 47426-303 | d2ca370f-32af-49ed-a8c2-bf8b3a0a43d3 | 1 | 2023-02-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EXPAREL | BUPIVACAINE | Pacira Pharmaceuticals, Inc. | bb5a9e59-0f51-11df-8a39-0800200c9a66 | 2026-11-09 | Warnings, Adverse reactions | Y8335394RO |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 445dc4f6-daac-e2f1-e063-6394a90a0ca5 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 453c5328-090e-0159-e063-6394a90a06b7 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 445d7cbf-bd3e-a54f-e063-6294a90a67a5 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Bryant Ranch Prepack | 7895f389-1509-4e03-8668-526ab1627fc8 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Bryant Ranch Prepack | 2322a070-25f0-4fc6-a98e-44ad1fb52dc5 | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| SYMBRAVO | MELOXICAM, RIZATRIPTAN | Axsome Therapeutics, Inc. | dcf1ecd1-08a0-8e47-e053-2a95a90abdc7 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | Redpharm Drug | 58d34e5d-4efb-3d76-e063-6394a90aa0f6 | 2026-10-02 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Zybic | MELOXICAM | Redmont Pharmaceuticals, LLC | a1c2d65f-ebb1-48bf-8fa1-c216f7d570ec | 2026-09-25 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Avondale Pharmaceuticals, LLC | 4ddf5a4d-8e84-419d-8e3a-c91b85501885 | 2026-09-25 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Direct_Rx | 58dcbc65-d126-7b48-e063-6294a90a52e9 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | REMEDYREPACK INC. | 385b7cf4-976a-4a58-9ebc-def8b6e78b75 | 2026-08-19 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | REMEDYREPACK INC. | cdd282df-572f-42a7-a1c6-a00e1bb4573d | 2026-08-18 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | Sportpharm LLC | f210e6b4-43b3-4d33-bc0b-013a0f907d3e | 2026-08-17 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Direct_Rx | 58dbce26-b2ac-2ce4-e063-6294a90a5727 | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | REMEDYREPACK INC. | 7048d6cc-88a7-4743-8481-63a2005fa27a | 2026-07-31 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | REMEDYREPACK INC. | f8c35ea4-d6ac-40c7-8f35-864fd1ec75d2 | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Dimethyl Sulfoxide | DIMETHYL SULFOXIDE | Renova Pharmaceuticals LLC | 8f699de6-9d09-48da-9d95-4001d7008587 | 2026-07-20 | Warnings, Adverse reactions | YOW8V9698H |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 5488ccc1-e416-e5d7-e063-6294a90a6cb8 | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 548ec3b7-2b6d-cd9e-e063-6394a90a78ff | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.